Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million ≈ $2.28 Million USD) by net assets (CN¥5.73 Billion ≈ $838.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Wuhan Easy Diagnosis Biomedicine Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret AS IS:BRISA	0.058x
YLZ Information Tech Co SHE:300096	-0.049x
Capex S.A BA:CAPX	0.012x
Chengdu Screen Micro-Electronics Co. Ltd. A SHG:688053	N/A
Polyrocks Chemical Co Ltd SHG:688669	0.030x
Zhejiang Jiaxin Silk Corp Ltd SHE:002404	-0.073x
Taiwan Sakura Corp TW:9911	0.059x
Sanlux Co Ltd SHE:002224	-0.001x

Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2024)

The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002932 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.02 Billion ≈ $880.72 Million	CN¥-85.05 Million ≈ $-12.44 Million	-0.014x	-122.65%
2023-12-31	CN¥6.29 Billion ≈ $920.73 Million	CN¥392.50 Million ≈ $57.43 Million	0.062x	-89.47%
2022-12-31	CN¥6.77 Billion ≈ $990.93 Million	CN¥4.01 Billion ≈ $587.21 Million	0.593x	+49.86%
2021-12-31	CN¥2.85 Billion ≈ $417.06 Million	CN¥1.13 Billion ≈ $164.92 Million	0.395x	+22.57%
2020-12-31	CN¥1.11 Billion ≈ $163.14 Million	CN¥359.68 Million ≈ $52.63 Million	0.323x	+783.28%
2019-12-31	CN¥615.62 Million ≈ $90.08 Million	CN¥22.49 Million ≈ $3.29 Million	0.037x	-59.67%
2018-12-31	CN¥592.59 Million ≈ $86.72 Million	CN¥53.67 Million ≈ $7.85 Million	0.091x	-52.68%
2017-12-31	CN¥242.93 Million ≈ $35.55 Million	CN¥46.50 Million ≈ $6.80 Million	0.191x	-43.07%
2016-12-31	CN¥175.08 Million ≈ $25.62 Million	CN¥58.86 Million ≈ $8.61 Million	0.336x	-13.84%
2015-12-31	CN¥115.39 Million ≈ $16.89 Million	CN¥45.02 Million ≈ $6.59 Million	0.390x	+17.45%
2014-12-31	CN¥49.59 Million ≈ $7.26 Million	CN¥16.47 Million ≈ $2.41 Million	0.332x	-28.26%
2013-12-31	CN¥13.60 Million ≈ $1.99 Million	CN¥6.30 Million ≈ $921.32K	0.463x	-36.17%
2012-12-31	CN¥1.42 Million ≈ $208.28K	CN¥1.03 Million ≈ $151.10K	0.725x	+103.22%
2011-12-31	CN¥21.45K ≈ $3.14K	CN¥-482.90K ≈ $-70.66K	-22.514x	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$577.41 Million

CN¥3.95 Billion CNY

Market Cap Rank

#11805 Global

#3617 in China

Share Price

CN¥16.97

Change (1 day)

+0.41%

52-Week Range

CN¥15.90 - CN¥22.86

All Time High

CN¥49.58